These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 17065340)
1. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats. Chelikani PK; Haver AC; Reidelberger RD Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340 [TBL] [Abstract][Full Text] [Related]
2. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Brennan IM; Otto B; Feltrin KL; Meyer JH; Horowitz M; Feinle-Bisset C Peptides; 2007 Mar; 28(3):607-11. PubMed ID: 17129639 [TBL] [Abstract][Full Text] [Related]
3. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner. Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060 [TBL] [Abstract][Full Text] [Related]
4. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Chelikani PK; Haver AC; Reidelberger RD Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384 [TBL] [Abstract][Full Text] [Related]
5. Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats. Chen CY; Chao Y; Chang FY; Chien EJ; Lee SD; Doong ML Int J Mol Med; 2005 Oct; 16(4):695-9. PubMed ID: 16142407 [TBL] [Abstract][Full Text] [Related]
6. Effect of peripherally administered ghrelin on gastric emptying and acid secretion in the rat. Levin F; Edholm T; Ehrström M; Wallin B; Schmidt PT; Kirchgessner AM; Hilsted LM; Hellström PM; Näslund E Regul Pept; 2005 Nov; 131(1-3):59-65. PubMed ID: 16040140 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of peptide YY(3-36) on conditioned taste aversion in rats. Chelikani PK; Haver AC; Reidelberger RD Peptides; 2006 Dec; 27(12):3193-201. PubMed ID: 16962209 [TBL] [Abstract][Full Text] [Related]
8. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438 [TBL] [Abstract][Full Text] [Related]
9. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Chelikani PK; Haver AC; Reidelberger RD Endocrinology; 2005 Feb; 146(2):879-88. PubMed ID: 15539554 [TBL] [Abstract][Full Text] [Related]
10. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917 [TBL] [Abstract][Full Text] [Related]
11. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man. Long SJ; Sutton JA; Amaee WB; Giouvanoudi A; Spyrou NM; Rogers PJ; Morgan LM Br J Nutr; 1999 Apr; 81(4):273-9. PubMed ID: 10999014 [TBL] [Abstract][Full Text] [Related]
12. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Freeland KR; Wolever TM Br J Nutr; 2010 Feb; 103(3):460-6. PubMed ID: 19818198 [TBL] [Abstract][Full Text] [Related]
13. The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat. Abbott CR; Small CJ; Sajedi A; Smith KL; Parkinson JR; Broadhead LL; Ghatei MA; Bloom SR Int J Obes (Lond); 2006 Feb; 30(2):288-92. PubMed ID: 16231018 [TBL] [Abstract][Full Text] [Related]
14. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Riediger T; Bothe C; Becskei C; Lutz TA Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809 [TBL] [Abstract][Full Text] [Related]
15. Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. Falkén Y; Hellström PM; Sanger GJ; Dewit O; Dukes G; Grybäck P; Holst JJ; Näslund E Neurogastroenterol Motil; 2010 Jun; 22(6):e192-200. PubMed ID: 20100281 [TBL] [Abstract][Full Text] [Related]
17. Effects of peripheral administration of PYY3-36 on feed intake and plasma acyl-ghrelin levels in pigs. Ito T; Thidarmyint H; Murata T; Inoue H; Neyra RM; Kuwayama H J Endocrinol; 2006 Oct; 191(1):113-9. PubMed ID: 17065394 [TBL] [Abstract][Full Text] [Related]
18. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats. Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. Chelikani PK; Haver AC; Reidelberger RD Am J Physiol Regul Integr Comp Physiol; 2004 Nov; 287(5):R1064-70. PubMed ID: 15242829 [TBL] [Abstract][Full Text] [Related]
20. Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats. Nakade Y; Tsukamoto K; Pappas TN; Takahashi T Brain Res; 2006 Sep; 1111(1):117-21. PubMed ID: 16884700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]